24 oct 2017
CPhI Worldwide 2017
LABDHI PHARMACEUTICALS

LABDHI PHARMACEUTICALS

Exhibitor at CPhI Worldwide 2017 stand 90B70, Finished Dosage Formulations

About us

Established in 1981, Labdhi Pharmaceuticals is an Indian business entity that is rapidly making its mark in the global pharmaceutical & life science sector. Labdhi products treat Cancer, Cardiovascular, HIV, Hormonal, Diabetes, Osteoporosis and many other conditions, globally. We are one of the very few manufacturers globally of the following products:- 1) Benztropine Mesylate Injection 2) Levothyroxine Injection 3) Menadion Injections USP 4) Pentoxifyllin Tablets USP. Visit our website http://www.labdhipharma.com/products1.php. All our products are manufactured in WHO-GMP Certified facilities to meet International Standards and government norms & also have different plant accreditations such as “EU – GMP”, “TGA (Australia)” and “INVIMA (Colombia)”.

Specs about this supplier

Sales markets Western Europe; Eastern Europe; Middle East; Asia; Australia; North America; Africa; Central/South America

Products featured at CPhI Worldwide 2017

LABDHI PHARMACEUTICALS

Event information

CPhI Worldwide 2017

24 - 26 October 2017 Messe Frankfurt, Germany Visit us at stand 90B70